Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: Over-expression of the high-affinity receptor EDG4 in differentiated thyroid cancer

International Journal of Cancer

Volumn 92, Issue 2, 2001, Pages 249-256

  Schulte, Klaus Martin ^a   Beyer, Andreas ^a   Khrer, Karl ^a   Oberhuser, Simone ^a   Rher, Hans Dietrich ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cancer; EDG; Lysophosphatidic acid; Phospholipids; Thyroid

Indexed keywords

EDG4 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; RECEPTOR; THYROTROPIN; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CHROMOSOMAL LOCALIZATION; CYTOTOXICITY; GENE MAPPING; GOITER; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PLEIOTROPY; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THYROID CANCER; THYROID CELL;

ACYLTRANSFERASES; ADULT; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GOITER; GROWTH SUBSTANCES; HUMANS; LYSOPHOSPHOLIPIDS; MALE; MIDDLE AGED; PHOSPHOLIPASES A; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; RNA, MESSENGER; THYROID GLAND; THYROID NEOPLASMS; TRANS-ACTIVATION (GENETICS);

EID: 0035871981     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200102)9999:9999<::AID-IJC1166>3.0.CO;2-D     Document Type: Article

References (60)

1. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer
2. Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells
3. LPA: A novel lipid mediator with diverse biological actions
4. Lysophosphatidic acid signalling
5. Lysophosphatidic acid, a multifunctional phospholipid messenger
6. Lysophosphatidic acid: G-protein signalling and cellular responses
7. Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid
8. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acylchain length and inhibition by suramin
9. Lysophosphatidic acid modulates intestinal epithelial cell function in vitro
10. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing
11. A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs)
12. Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid
13. Complete cDNA sequence, genomic structure, and chromosomal localization of the LPA receptor gene, 1pA1/vzg-1/Gpcr26
14. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex
15. A single receptor encoded by vzg-1/1pA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid
16. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid
17. Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate
18. Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes
19. Lysophosphatidic acid stimulates the G-protein-coupled receptor EDG-1 as a low affinity agonist
20. EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16
21. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1
22. Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca(2+) signaling pathway
23. 2 gene multiple enzymes with distinct properties from a single gene
24. 2 inhibitory proteins from pig thyroid gland
25. Cloning and expression of two human lysophosphatidic acid acyltransferase cDNAs that enhance cytokine-induced signaling responses in cells
26. Growth factors in thyroid cells
27. Molecular genetics of thyroid diseases
28. Molecular basis of epithelial tumorigenesis: The thyroid model
29. Thyrotropin is a potent growth factor for normal human thyroid cells in primary culture
30. Evidence for autocrine production of IGF-1 in human thyroid adenomas
31. Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues
32. Mitogenic stimulation of normal and oncogene-transformed human thyroid epithelial cells by hepatocyte growth factor
33. The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome
34. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas
35. Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma
36. Tumour-suppressor genes: Evolving definitions in the genomic age
37. The bioactive phospholipid lysophosphatidic acid is released from activated platelets
38. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells
39. Immunochemical quantitation of bromodeoxyuridine: Application to cell-cycle kinetics
40. A single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
41. Genomic characterization of the lysophosphatidic acid receptor gene, 1p(A2)/Edg4, and identification of a frameshift mutation in a previously characterized cDNA
42. A fine physical map of the CACNA1A gene region on 19p13.1-p13.2 chromosome
43. Genetic linkage mapping of the dehydroepiandrosterone sulfotransferase (STD) gene on the chromosome 19q13.3 region
44. Fine mapping and haplotype analysis of the locus for congenital nephrotic syndrome on chromosome 19q13.1
45. 2+ mobilization in human A431 cells: Structure-activity analysis
46. Lysophosphatidic acid-induced proliferation-related signals in astrocytes
47. Serum-induced membrane depolarization in quiescent fibroblasts: Activation of a chloride conductance through the G protein-coupled LPA receptor
48. Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway
49. Signalling pathways involved in the mitogenic action of lysophosphatidylinositol
50. Elevated levels and mitogenic activity of lysophosphatidylinositol in k-ras-transformed epithelial cells
51. An EGF receptor-mediated signal attenuates the inhibitory effect of LPA on an adenylate cyclase activity
52. Lysophospholipids activate ovarian and breast cancer cells
53. Thyrotropin-dependent transforming growth factor beta expression in thyroid gland
54. Growth regulation of thyroid and thyroid tumors in humans
55. Identification of a novel growth factor-like lipid, 1-O-cis-alk-1′-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial sphingolipid preparations
56. EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue
57. Lysophospholipid enhancement of human T cell sensitivity to diphtheria toxin by increased expression of heparin-binding epidermal growth factor
58. Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules
59. Effect of lysophosphatidic acid on motility, polarisation and metabolic burst of human neutrophils
60. Tumor invasion: Role of growth factor-induced cell motility